Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AZGP1 pseudogene 2 (AZGP1P2), also listed as Putative zinc-alpha-2-glycoprotein-like 2 and similar names, is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but typically lack protein-coding potential and do not produce functional proteins. AZGP1P2 is related by sequence to the functional gene AZGP1 (encoding zinc-alpha-2-glycoprotein), but it does not encode a functional protein and has no demonstrated, direct biological or therapeutic relevance. There is no evidence it serves as a drug target, biomarker, or mediator of biological functions or disease. In the context of molecular targeting, only the functional AZGP1 gene/protein (not the pseudogene AZGP1P2) is referenced in the literature as involved in lipid metabolism, immune regulation, or cancer biology[1][2][3][4][5][6]. The pseudogene entry does not correspond to a clinically or pharmacologically actionable target; its inclusion as a protein or receptor would be incorrect. Note: If you are seeking information on a therapeutic target, AZGP1 (not AZGP1P2) may be of interest. AZGP1 itself is a functional protein with roles in lipid metabolism and cancer but AZGP1P2 is a non-coding, non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AZGP1 pseudogene 2 (AZGP1P2).